Inovio Pharmaceuticals, Inc. (INO) stock
INONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.69+0.06 (+3.68%)
Close on Nov 18, 2026Market cap $174.74MP/E –Yield –
Inovio Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Inovio Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$80.58M. For fiscal 2025 it was -$88.63M. The highest annual figure on record is -$11.94M in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$88.63M | – |
| FY2024 | Dec 31, 2024 | -$104.08M | – |
| FY2023 | Dec 31, 2023 | -$124.37M | – |
| FY2022 | Dec 31, 2022 | -$216.22M | – |
| FY2021 | Dec 31, 2021 | -$215.71M | – |
| FY2020 | Dec 31, 2020 | -$177.98M | – |
| FY2019 | Dec 31, 2019 | -$97.85M | – |
| FY2018 | Dec 31, 2018 | -$73.55M | – |
| FY2017 | Dec 31, 2017 | -$63.21M | – |
| FY2016 | Dec 31, 2016 | -$62.56M | – |
| FY2015 | Dec 31, 2015 | -$12.44M | – |
| FY2014 | Dec 31, 2014 | -$29.82M | – |
| FY2013 | Dec 31, 2013 | -$15.38M | – |
| FY2012 | Dec 31, 2012 | -$22.31M | – |
| FY2011 | Dec 31, 2011 | -$19.76M | – |
| FY2010 | Dec 31, 2010 | -$11.94M | – |
| FY2009 | Dec 31, 2009 | -$14.08M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$18.05M | – |
| Q1 FY2026 | Mar 31, 2026 | -$21.59M | – |
| Q4 FY2025 | Dec 31, 2025 | -$19.37M | – |
| Q3 FY2025 | Sep 30, 2025 | -$21.57M | – |
| Q2 FY2025 | Jun 30, 2025 | -$20.81M | – |
| Q1 FY2025 | Mar 31, 2025 | -$26.87M | – |
| Q4 FY2024 | Dec 31, 2024 | -$19.66M | – |
| Q3 FY2024 | Sep 30, 2024 | -$27.44M | – |
| Q2 FY2024 | Jun 30, 2024 | -$28.21M | – |
| Q1 FY2024 | Mar 31, 2024 | -$28.76M | – |
| Q4 FY2023 | Dec 31, 2023 | -$26.28M | – |
| Q3 FY2023 | Sep 30, 2023 | -$29.11M | – |
| Q2 FY2023 | Jun 30, 2023 | -$32.31M | – |
| Q1 FY2023 | Mar 31, 2023 | -$36.66M | – |
| Q4 FY2022 | Dec 31, 2022 | -$36.34M | – |
| Q3 FY2022 | Sep 30, 2022 | -$67.47M | – |
| Q2 FY2022 | Jun 30, 2022 | -$50.53M | – |
| Q1 FY2022 | Mar 31, 2022 | -$61.88M | – |
| Q4 FY2021 | Dec 31, 2021 | -$37.89M | – |
| Q3 FY2021 | Sep 30, 2021 | -$46.49M | – |
| Q2 FY2021 | Jun 30, 2021 | -$78.46M | – |
| Q1 FY2021 | Mar 31, 2021 | -$52.87M | – |
| Q4 FY2020 | Dec 31, 2020 | -$51.22M | – |
| Q3 FY2020 | Sep 30, 2020 | -$74.16M | – |
| Q2 FY2020 | Jun 30, 2020 | -$27.15M | – |
| Q1 FY2020 | Mar 31, 2020 | -$25.45M | – |
| Q4 FY2019 | Dec 31, 2019 | -$13.74M | – |
| Q3 FY2019 | Sep 30, 2019 | -$27.73M | – |
| Q2 FY2019 | Jun 30, 2019 | -$23.92M | – |
| Q1 FY2019 | Mar 31, 2019 | -$32.45M | – |
| Q4 FY2018 | Dec 31, 2018 | -$17.28M | – |
| Q3 FY2018 | Sep 30, 2018 | -$24.67M | – |
| Q2 FY2018 | Jun 30, 2018 | -$19.02M | – |
| Q1 FY2018 | Mar 31, 2018 | -$12.58M | – |
| Q4 FY2017 | Dec 31, 2017 | -$13.95M | – |
| Q3 FY2017 | Sep 30, 2017 | -$17.31M | – |
| Q2 FY2017 | Jun 30, 2017 | -$16.72M | – |
| Q1 FY2017 | Mar 31, 2017 | -$15.23M | – |
| Q4 FY2016 | Dec 31, 2016 | -$14.90M | – |
| Q3 FY2016 | Sep 30, 2016 | -$18.64M | – |
See a number that looks wrong?